Calix Inc

Bernstein Liebhard LLP announced an investigation into potential breaches of fiduciary duty by certain directors and officers of Calix, Inc. The law firm is examining whether Calix leadership acted in the best interests of shareholders and whether legal remedies may be available. Current Calix shareholders who purchased shares before January 28, 2026 are encouraged to contact the firm to discuss their legal rights. Bernstein Liebhard has recovered more than $3.5 billion for clients since 1993.

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Calix Inc. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired Calix securities between January 28, 2026 and April 21, 2026. The complaint claims the company failed to disclose that first quarter margins benefited from advanced purchasing of memory components, that the advanced supply was dwindling, and that the company faced negative margin pressure as it had to buy memory components at rising market prices. Investors have until July 27, 2026 to seek lead plaintiff appointment.

Bragar Eagel & Squire, P.C. reminds investors who purchased or acquired Calix, Inc. securities between January 28, 2026 and April 21, 2026 that they have until July 27, 2026 to seek appointment as lead plaintiff in a pending class action lawsuit. The suit, filed in the United States District Court for the Northern District of California, alleges that Calix and certain defendants made materially false and misleading statements and failed to disclose that the company's first quarter margins had been temporarily boosted by advanced purchasing of memory components, that this supply was dwindling, and that Calix was consequently facing negative margin pressure as it had to buy memory at rising market prices. Investors who suffered losses are encouraged to contact the firm's partners Brandon Walker or Melissa Fortunato at investigations@bespc.com or (212) 355-4648 to discuss their legal rights.

The Schall Law Firm reminds investors of a securities fraud class action against Calix, Inc. with a lead plaintiff deadline of July 27, 2026. The lawsuit covers investors who purchased Calix securities between January 28, 2026 and April 21, 2026, alleging the company made false and misleading statements about its margins and memory component supply. According to the complaint, Calix's first-quarter margins were temporarily boosted by advanced purchasing of memory components, but the supply was rapidly decreasing and margins faced negative pressure from rising market prices. When the market learned the truth, investors suffered damages.

Rosen Law Firm reminds purchasers of Calix, Inc. securities between January 28, 2026 and April 21, 2026 of the July 27, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Calix made false and misleading statements about its margins, failing to disclose that first-quarter margins had benefited from advanced purchasing of memory components, that the advanced supply was dwindling, and that the company was experiencing negative margin pressure as it was forced to buy memory components at rising market prices. Investors who purchased Calix securities during the class period may be entitled to compensation through a contingency fee arrangement. The Rosen Law Firm, which has recovered billions of dollars for investors and was ranked number one by ISS Securities Class Action Services for settlements in 2017, encourages investors to select qualified counsel.

The Law Offices of Howard G. Smith reminds investors that securities fraud class action lawsuits have been filed against Calix, AeroVironment, Zoetis, and Lucid Group, with lead plaintiff deadlines approaching. For Calix, the class period is January 28, 2026 to April 21, 2026, and the lead plaintiff deadline is July 27, 2026; the complaint alleges the company misled investors about margin pressures from dwindling advanced memory component supplies. AeroVironment faces a class period from June 25, 2025 to March 10, 2026, with a July 27, 2026 deadline, over claims it understated imminent competition for SCAR program and Space Force work. Zoetis has a class period of January 14, 2025 to May 6, 2026, and a July 27, 2026 deadline, with allegations it concealed weakening Librela adoption, market share losses for Simparica Trio, and competitive pressures on Apoquel and Cytopoint. Lucid Group's class period runs from February 25, 2026 to April 13, 2026, with a July 28, 2026 deadline, based on claims it failed to disclose a supplier quality issue that disrupted Lucid Gravity deliveries and materially impacted financial results.

Glancy Prongay Wolke & Rotter LLP reminds Calix, Inc. shareholders of a July 27, 2026 deadline to move for lead plaintiff in a class action covering purchases between January 28 and April 21, 2026. The suit follows an April 21, 2026 disclosure that first-quarter non-GAAP gross margin fell 80 basis points sequentially to 57.2%, and second-quarter guidance of 55.8% at the midpoint reflects a 140-basis-point drop driven by higher memory component costs after advanced supply ran out. On that news, Calix shares fell $6.93, or 13.98%, to $42.65 on April 22, 2026. The complaint alleges the company failed to disclose that first-quarter margins had benefited from advanced purchasing, that the advanced supply was dwindling, and that rising market prices were creating negative margin pressure, rendering positive statements misleading.

The Portnoy Law Firm has announced a class action lawsuit on behalf of Calix, Inc. investors who purchased securities between January 28, 2026 and April 21, 2026. Investors have until July 27, 2026 to file a lead plaintiff motion. The lawsuit follows Calix's April 21, 2026 earnings report, which disclosed a sequential decline in non-GAAP gross margin to 57.2% and second-quarter guidance of 55.8% at the midpoint, down 140 basis points due to higher memory component costs. On an earnings call, CFO Cory Sindelar stated that advanced purchasing had previously shielded the company from these costs but that supply has now run out, and full-year non-GAAP gross margin is expected to decline between 50 and 150 basis points. On this news, Calix's stock price fell $6.93 per share, or 13.98%, to close at $42.65 per share on April 22, 2026.

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Calix, Inc. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired Calix securities between January 28, 2026 and April 21, 2026. The complaint claims the company failed to disclose that its first quarter margins had significantly benefited from advanced purchasing of memory components, that its advanced supply of memory components was dwindling, and that it was experiencing negative margin pressure as it was forced to purchase memory components at rising market prices. As a result, positive statements about the company’s margins, business, operations, and prospects were allegedly materially misleading. Investors have until July 27, 2026 to seek lead plaintiff appointment.

Robbins LLP reminds stockholders that a class action has been filed against Calix, Inc. on behalf of investors who purchased securities between January 28, 2026 and April 21, 2026. The lawsuit alleges the company misled investors by failing to disclose that its first quarter margins had benefited from advanced purchasing of memory components, that this supply was dwindling, and that the company faced negative margin pressure as it was forced to buy memory at rising market prices. When the truth was revealed on April 21, Calix’s stock fell $6.93, or 13.98%, to close at $42.65 per share on April 22, 2026. Shareholders who wish to serve as lead plaintiff must file papers with the court by July 27, 2026.

The Law Offices of Howard G. Smith reminds investors that securities fraud class action lawsuits have been filed against Calix, AeroVironment, Zoetis, and Lucid Group, with lead plaintiff deadlines approaching in late July 2026. The Calix lawsuit alleges the company misled investors about margin benefits from advanced memory component purchases and subsequent negative margin pressure, with a lead plaintiff deadline of July 27, 2026. AeroVironment faces claims it understated competition risks related to the SCAR program and U.S. Space Force modernization efforts, also with a July 27 deadline. Zoetis is accused of concealing weakening veterinarian adoption of Librela, market share losses for Simparica Trio, and competitive pressures on Apoquel and Cytopoint, with the same July 27 deadline. The Lucid Group action, with a July 28 deadline, alleges the company failed to disclose a supplier quality issue that disrupted Lucid Gravity deliveries and negatively impacted financial results.

Bernstein Liebhard LLP announced that a securities fraud class action lawsuit has been filed against Calix, Inc. on behalf of investors who purchased or acquired Calix securities between January 28, 2026 and April 21, 2026. The lawsuit alleges that defendants made materially false and misleading statements about the company's business operations, growth prospects, and financial stability, causing Calix securities to trade at artificially inflated prices during the class period. Investors who wish to serve as lead plaintiff must file papers by July 27, 2026. Bernstein Liebhard has recovered over $3.5 billion for clients since 1993.

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Calix, Inc. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired Calix securities between January 28, 2026 and April 21, 2026. The complaint claims that during this period, defendants failed to disclose that first quarter margins had significantly benefited from advanced purchasing of memory components, that the advanced supply was dwindling, and that the company was experiencing negative margin pressure as it was forced to buy memory components at rising market prices. As a result, positive statements about margins, business, operations, and prospects were allegedly materially misleading. Investors have until July 27, 2026 to seek lead plaintiff appointment.

Holzer & Holzer reminds investors of upcoming deadlines to seek lead plaintiff appointment in shareholder class action lawsuits against Calix, AeroVironment, and Lucid Group. The Calix case concerns alleged misstatements about advanced purchasing of memory components between January 28 and April 21, 2026, with a July 27, 2026 deadline. The AeroVironment lawsuit involves claims regarding the competitive landscape from June 25, 2025 to March 10, 2026, also with a July 27, 2026 deadline. The Lucid Group action alleges false or misleading statements about manufacturing and delivery capabilities between February 25 and April 13, 2026, with a July 28, 2026 deadline. Investors who purchased shares during the relevant periods and suffered losses are encouraged to contact the firm.

A securities class action has been filed against Calix, Inc. and two of its senior executives, alleging they made materially misleading statements about the company's gross margins between January 28 and April 21, 2026. The complaint names CEO Michael Weening and CFO Cory Sindelar as individual defendants, claiming they controlled the dissemination of false information regarding Calix's supply of lower-cost memory components and the resulting margin pressure. When the truth emerged on April 21, 2026, Calix shares fell 42.65% the following day on unusually heavy volume. The lawsuit asserts claims under Section 20(a) of the Securities Exchange Act of 1934 and cites Sarbanes-Oxley certifications in which the executives personally attested to the accuracy of financial reports. The court has set July 27, 2026 as the deadline for investors to apply for lead plaintiff appointment.

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Calix, Inc. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired Calix securities between January 28, 2026 and April 21, 2026. The complaint claims the company failed to disclose that its first quarter margins benefited from advanced purchasing of memory components, that this supply was dwindling, and that the company faced negative margin pressure as it had to buy memory at rising market prices. Investors have until July 27, 2026 to seek lead plaintiff appointment.

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Calix, Inc. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired Calix securities between January 28, 2026 and April 21, 2026. The complaint claims the company failed to disclose that its first quarter margins benefited from advanced purchasing of memory components, that this supply was dwindling, and that it faced negative margin pressure as it had to buy memory at rising market prices. Investors have until July 27, 2026 to seek lead plaintiff appointment. The law firm represents investors on a contingency fee basis.

Rosen Law Firm reminds purchasers of Calix securities between January 28, 2026 and April 21, 2026 of the July 27, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Calix made false and misleading statements about its margins, failing to disclose that first-quarter margins had benefited from advanced purchasing of memory components, that the advanced supply was dwindling, and that the company was experiencing negative margin pressure as it was forced to buy memory components at rising market prices. Investors who purchased Calix securities during the class period may be entitled to compensation through a contingency fee arrangement. A class action has already been filed, and investors seeking to serve as lead plaintiff must move the Court by July 27, 2026.

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Calix, Inc. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired Calix securities between January 28, 2026 and April 21, 2026. The complaint claims the company failed to disclose that first-quarter margins benefited from advanced memory component purchases, that this supply was dwindling, and that the company faced negative margin pressure as it had to buy components at rising market prices. Investors have until July 27, 2026 to seek lead plaintiff appointment. The law firm is handling the case on a contingency fee basis.

Kirby McInerney LLP reminds Calix, Inc. investors of the July 27, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. The lawsuit, filed on behalf of purchasers of Calix securities between January 28, 2026 and April 21, 2026, alleges that the company's first quarter margins had significantly benefited from advanced purchasing of memory components, that its advanced supply was dwindling, and that it consequently faced negative margin pressure as it was forced to buy memory components at rising market prices. On April 21, 2026, Calix reported first quarter 2026 earnings showing non-GAAP gross margin of 57.2%, down 80 basis points sequentially, and guided second quarter gross margin between 54.25% and 57.25%, with full-year non-GAAP gross margin expected to decline between 50 and 150 basis points. The CFO stated during the earnings call that advanced purchasing had allowed the company to avoid higher memory component costs during the first quarter, but that supply had run its course and the company now faced market prices. Calix shares fell $6.93, or approximately 14%, from $49.58 on April 21, 2026 to close at $42.65 on April 22, 2026.